H.‐J. Malling

3.5k total citations · 1 hit paper
25 papers, 2.6k citations indexed

About

H.‐J. Malling is a scholar working on Immunology and Allergy, Physiology and Pharmacology. According to data from OpenAlex, H.‐J. Malling has authored 25 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology and Allergy, 10 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in H.‐J. Malling's work include Allergic Rhinitis and Sensitization (15 papers), Food Allergy and Anaphylaxis Research (11 papers) and Asthma and respiratory diseases (10 papers). H.‐J. Malling is often cited by papers focused on Allergic Rhinitis and Sensitization (15 papers), Food Allergy and Anaphylaxis Research (11 papers) and Asthma and respiratory diseases (10 papers). H.‐J. Malling collaborates with scholars based in Denmark, Germany and United Kingdom. H.‐J. Malling's co-authors include R.F. Lockey, J Bousquet, Jean Bousquet, R. Djurup, Giorgio Walter Canonica, Claus Bachert, S. R. Durham, Peter Howarth, Niels Mygind and Desiderio Passàli and has published in prestigious journals such as The Lancet, Journal of Allergy and Clinical Immunology and Journal of Immunological Methods.

In The Last Decade

H.‐J. Malling

25 papers receiving 2.4k citations

Hit Papers

Allergen immunotherapy: Therapeutic vaccines for allergic... 1998 2026 2007 2016 1998 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.‐J. Malling Denmark 15 2.2k 1.7k 996 279 167 25 2.6k
Javier Cuesta‐Herranz Spain 30 1.8k 0.8× 530 0.3× 915 0.9× 65 0.2× 22 0.1× 88 2.3k
W. FRAIN-BELL United Kingdom 24 143 0.1× 70 0.0× 902 0.9× 178 0.6× 57 0.3× 68 1.4k
S. Frémont France 21 690 0.3× 147 0.1× 284 0.3× 64 0.2× 14 0.1× 61 1.4k
M. D. Alonso Spain 19 930 0.4× 246 0.1× 379 0.4× 41 0.1× 9 0.1× 45 1.3k
Ernesto Enrique Spain 22 1.6k 0.7× 412 0.2× 807 0.8× 53 0.2× 11 0.1× 62 2.0k
Marco Ispano Italy 18 1.6k 0.7× 213 0.1× 924 0.9× 20 0.1× 18 0.1× 26 1.9k
Pedro Gamboa Spain 24 1.2k 0.6× 455 0.3× 528 0.5× 89 0.3× 13 0.1× 65 1.7k
Laura Farioli Italy 24 2.0k 0.9× 211 0.1× 1.1k 1.1× 29 0.1× 22 0.1× 47 2.3k
E González-Mancebo Spain 18 1.3k 0.6× 349 0.2× 702 0.7× 68 0.2× 8 0.0× 50 1.5k
Miranda Sin‐Man Tsang Hong Kong 16 144 0.1× 190 0.1× 247 0.2× 45 0.2× 11 0.1× 31 809

Countries citing papers authored by H.‐J. Malling

Since Specialization
Citations

This map shows the geographic impact of H.‐J. Malling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.‐J. Malling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.‐J. Malling more than expected).

Fields of papers citing papers by H.‐J. Malling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.‐J. Malling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.‐J. Malling. The network helps show where H.‐J. Malling may publish in the future.

Co-authorship network of co-authors of H.‐J. Malling

This figure shows the co-authorship network connecting the top 25 collaborators of H.‐J. Malling. A scholar is included among the top collaborators of H.‐J. Malling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.‐J. Malling. H.‐J. Malling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winther, Lone, Lars K. Poulsen, Blaise Robin, Michel Mélac, & H.‐J. Malling. (2009). Safety and Tolerability of Recombinant Bet v 1 (rBet v 1) Tablets in Sublingual Immunotherapy (SLIT). Journal of Allergy and Clinical Immunology. 123(2). S215–S215. 16 indexed citations
2.
Malling, H.‐J.. (2000). Minimising the Risks of Allergen-Specific Injection Immunotherapy. Drug Safety. 23(4). 323–332. 52 indexed citations
3.
Cauwenberge, Paul Van, Claus Bachert, G. Passalacqua, et al.. (2000). Consensus statement * on the treatment of allergic rhinitis. Allergy. 55(2). 116–134. 499 indexed citations
4.
Malling, H.‐J.. (1999). [WHO position paper (summary)--allergen-immunotherapy: therapeutic vaccines for allergic diseases].. PubMed. 149(14-15). 410–4. 6 indexed citations
5.
Bousquet, J, R.F. Lockey, & H.‐J. Malling. (1998). Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper. Journal of Allergy and Clinical Immunology. 102(4). 558–562. 1238 indexed citations breakdown →
6.
Malling, H.‐J., Bengt Björkstén, Jean Bousquet, et al.. (1998). Local immunotherapy. Allergy. 53(10). 933–943. 97 indexed citations
7.
Rønborg, Steen, et al.. (1996). [Adrenaline for self treatment of anaphylactic reactions. Indications, available preparations and prescription rules].. PubMed. 158(32). 4539–43. 2 indexed citations
8.
Lehrer, S.B., Janet Hughes, L.C. Altman, et al.. (1994). Prevalence of basidiomycete allergy in the USA and Europe and its relationship to allergic respiratory symptoms. Allergy. 49(6). 460–465. 64 indexed citations
9.
Poulsen, Lars K., et al.. (1991). 770 The SPT scanner — an objective and precise method for evaluation of skin prick test wheal areas. Journal of Allergy and Clinical Immunology. 87(1). 332–332. 2 indexed citations
10.
Thompson, R.A., Jean Bousquet, P. C. Frei, et al.. (1989). Current status of allergen immunotherapy. The Lancet. 1(8632). 259–261. 35 indexed citations
11.
Malling, H.‐J. & R. Djurup. (1988). Diagnosis and immunotherapy of mould allergy. Allergy. 43(1). 60–70. 51 indexed citations
12.
Malling, H.‐J. & P. Stahl Skov. (1988). Diagnosis and immunotherapy of mould allergy. VIII. Qualitative and quantitative estimation of IgE in Cladosporium immunotherapy.. PubMed. 43(3). 228–38. 12 indexed citations
13.
Malling, H.‐J. & P. Stahl Skov. (1988). Diagnosis and immunotherapy of mould allergy. Allergy. 43(3). 228–238. 11 indexed citations
14.
Bousquet, Jean, UA Müller, Sten Dreborg, et al.. (1987). Immunotherapy with Hymenoptera venoms. Allergy. 42(6). 401–413. 95 indexed citations
15.
Malling, H.‐J., R. Djurup, I. Søndergaard, & B. Weeke. (1985). Clustered Immunotherapy with Yellow Jacket Venom. Allergy. 40(5). 373–383. 28 indexed citations
16.
Djurup, R., H.‐J. Malling, I. Søndergaard, & B. Weeke. (1985). The Ige and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regiments of venom immunotherapy. Journal of Allergy and Clinical Immunology. 76(1). 46–55. 57 indexed citations
17.
Malling, H.‐J.. (1971). Dimethylnitrosamine: formation of mutagenic compounds by interaction with mouse liver microsomes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 13(4). 425–429. 207 indexed citations
18.
Frederiksen, S., H.‐J. Malling, & Hans Klenow. (1965). Isolation of 3′-deoxyadenosine (cordycepin) from the liquid medium of Cordyceps militaris (L. ex Fr.) Link. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 95(2). 189–193. 34 indexed citations
19.
Malling, H.‐J. & S. Frederiksen. (1962). Induction of reversions in Neurospora crassa by nitrous acid. Fungal Genetics Reports. 2(1). 9–10. 1 indexed citations
20.
Malling, H.‐J., H.G. Miltenburger, Maria Lurenda Westergaard, & K. Zimmer. (1959). Differential Response of a Double Mutant–adenineless, Inositolless-in Neurospora Crassa to Combined Treatment by Ultra-violet Radiation and Chemicals. International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine. 1(4). 328–343. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026